Archean Chemical Industries Limited
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
Key metrics
Price as of 2026-07-17
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 343 Cr | 290 Cr | 413 Cr | 284 Cr | 213 Cr | 240 Cr | 242 Cr | 346 Cr | 292 Cr | 233 Cr | 255 Cr | 301 Cr |
| Operating expenses (approx.) | 208 Cr | 195 Cr | 267 Cr | 185 Cr | 141 Cr | 206 Cr | 162 Cr | 249 Cr | 214 Cr | 171 Cr | 200 Cr | 252 Cr |
| EBITDA | 135 Cr | 95 Cr | 145 Cr | 99 Cr | 71 Cr | 35 Cr | 80 Cr | 96 Cr | 78 Cr | 63 Cr | 54 Cr | 49 Cr |
| OPM % | 39.2% | 32.9% | 35.2% | 34.9% | 33.5% | 14.4% | 33.0% | 27.8% | 26.7% | 26.8% | 21.4% | 16.3% |
| Other income | 11 Cr | 11 Cr | 9 Cr | 12 Cr | 10 Cr | 11 Cr | 9 Cr | 8 Cr | 8 Cr | 6 Cr | 7 Cr | 5 Cr |
| Interest | 3 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 3 Cr | 3 Cr | 0.29 Cr | 5 Cr | 6 Cr | 4 Cr | 10 Cr |
| Depreciation | 18 Cr | 18 Cr | 18 Cr | 18 Cr | 19 Cr | 19 Cr | 20 Cr | 21 Cr | 23 Cr | 24 Cr | 24 Cr | 23 Cr |
| Profit before tax | 125 Cr | 87 Cr | 135 Cr | 80 Cr | 61 Cr | 23 Cr | 66 Cr | 75 Cr | 58 Cr | 40 Cr | 33 Cr | 16 Cr |
| Tax % | 24.9% | 24.4% | 24.9% | 27.8% | 26.0% | 30.9% | 27.3% | 28.0% | 30.8% | 27.2% | 28.0% | 22.9% |
| Net profit | 94 Cr | 66 Cr | 102 Cr | 58 Cr | 45 Cr | 16 Cr | 48 Cr | 54 Cr | 40 Cr | 29 Cr | 24 Cr | 12 Cr |
| EPS (₹) | ₹7.63 | ₹5.36 | ₹8.24 | ₹4.65 | ₹3.64 | ₹1.28 | ₹3.89 | ₹4.33 | ₹3.25 | ₹2.36 | ₹1.92 | ₹1.13 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 1,441 Cr | 1,330 Cr | 1,041 Cr | 1,081 Cr | Sign in for TTM |
| Operating expenses (approx.) | 807 Cr | 867 Cr | 730 Cr | 815 Cr | Sign in for TTM |
| EBITDA | 634 Cr | 463 Cr | 311 Cr | 266 Cr | Sign in for TTM |
| OPM % | 44.0% | 34.8% | 29.9% | 24.6% | Sign in for TTM |
| Other income | 43 Cr | 43 Cr | 37 Cr | 27 Cr | Sign in for TTM |
| Interest | 97 Cr | 8 Cr | 8 Cr | 26 Cr | Sign in for TTM |
| Depreciation | 69 Cr | 70 Cr | 79 Cr | 93 Cr | Sign in for TTM |
| Profit before tax | 512 Cr | 427 Cr | 224 Cr | 147 Cr | Sign in for TTM |
| Tax % | 25.2% | 25.3% | 27.5% | 28.3% | Sign in for TTM |
| Net profit | 383 Cr | 319 Cr | 162 Cr | 105 Cr | Sign in for TTM |
| EPS (₹) | ₹34.66 | ₹25.90 | ₹13.13 | ₹8.66 | Sign in for TTM |
| Dividend payout % | 0.0% | 17.4% | 7.6% | 35.1% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity capital | 25 Cr | 25 Cr | 25 Cr | 25 Cr |
| Reserves | 1,406 Cr | 1,677 Cr | 1,839 Cr | 1,910 Cr |
| Borrowings | 21 Cr | 60 Cr | 26 Cr | 295 Cr |
| Other liabilities | 303 Cr | 295 Cr | 503 Cr | 437 Cr |
| Total liabilities | 1,755 Cr | 2,056 Cr | 2,393 Cr | 2,665 Cr |
| Fixed assets (net) | 1,110 Cr | 1,160 Cr | 1,378 Cr | 1,383 Cr |
| CWIP | 36 Cr | 46 Cr | 65 Cr | 72 Cr |
| Investments | 210 Cr | 350 Cr | 339 Cr | 257 Cr |
| Other assets | 577 Cr | 727 Cr | 692 Cr | 532 Cr |
| Total assets | 1,755 Cr | 2,056 Cr | 2,393 Cr | 2,665 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Cash from operating activity | 496 Cr | 379 Cr | 176 Cr | 140 Cr |
| Cash from investing | -290 Cr | -307 Cr | -246 Cr | -293 Cr |
| Cash from financing | -212 Cr | -33 Cr | 65 Cr | 154 Cr |
| Net cash flow | -6 Cr | 40 Cr | -5 Cr | 0.69 Cr |
| Free cash flow (OCF − Capex) | 396 Cr | 248 Cr | -87 Cr | -243 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| ROCE % | 38.9% | 22.3% | 12.3% | 7.8% |
| ROE % | 26.7% | 18.7% | 8.7% | 5.5% |
| Debtor days | 30 | 43 | — | — |
| Inventory days | 1336 | 976 | 972 | 892 |
| Days payable | 761 | 766 | — | — |
| Cash conversion cycle | 605 | 254 | 972 | 892 |
| Debt / equity | 0.02 | 0.03 | 0.01 | 0.15 |
| Current ratio | 3.35 | 5.38 | 3.50 | 1.21 |
| Net debt / EBITDA | 0.02 | 0.03 | -0.05 | 0.95 |
Compare with peers
Loading peers…